Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 23 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.93 Insider Own1.66% Shs Outstand15.61M Perf Week-6.35%
Market Cap2.28M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float15.35M Perf Month-12.26%
Income-5.08M PEG- EPS next Q- Inst Own1.95% Short Float0.83% Perf Quarter-18.80%
Sales12.31M P/S0.19 EPS this Y- Inst Trans-0.66% Short Ratio0.05 Perf Half Y-83.02%
Book/sh0.49 P/B0.30 EPS next Y- ROA-35.56% Short Interest0.13M Perf Year-89.86%
Cash/sh0.15 P/C0.95 EPS next 5Y- ROE-82.87% 52W Range0.12 - 1.52 Perf YTD-19.07%
Dividend Est.- P/FCF- EPS past 5Y44.36% ROI-74.08% 52W High-90.39% Beta1.27
Dividend TTM- Quick Ratio3.02 Sales past 5Y-2.96% Gross Margin36.70% 52W Low25.97% ATR (14)0.02
Dividend Ex-Date- Current Ratio3.98 EPS Y/Y TTM59.42% Oper. Margin-36.06% RSI (14)38.84 Volatility7.17% 15.15%
Employees171 Debt/Eq0.06 Sales Y/Y TTM-1.96% Profit Margin-41.23% Recom1.00 Target Price3.25
Option/ShortNo / Yes LT Debt/Eq0.02 EPS Q/Q87.28% Payout- Rel Volume0.10 Prev Close0.15
Sales Surprise- EPS Surprise- Sales Q/Q6.59% EarningsFeb 09 BMO Avg Volume2.59M Price0.15
SMA20-9.77% SMA50-14.37% SMA200-77.21% Trades Volume270,723 Change-4.95%
Feb-08-24 04:10PM
Jan-23-24 07:30AM
Jan-09-24 09:15AM
Nov-13-23 04:10PM
Nov-03-23 07:30AM
09:10AM Loading…
Oct-26-23 09:10AM
Sep-21-23 09:35AM
Aug-15-23 07:30AM
Aug-10-23 04:15PM
Aug-03-23 07:30AM
Jun-22-23 07:30AM
Jun-09-23 04:40PM
Jun-08-23 04:01PM
Apr-19-23 01:30PM
Apr-11-23 07:30AM
04:15PM Loading…
Mar-28-23 04:15PM
Mar-02-23 07:30AM
Feb-14-23 04:30PM
Jan-31-23 07:30AM
Jan-25-23 07:30AM
Jan-04-23 07:30AM
Nov-17-22 05:33AM
Nov-14-22 04:15PM
Oct-27-22 04:01PM
Oct-06-22 04:15PM
Aug-11-22 04:30PM
Aug-02-22 04:30PM
Jul-13-22 04:45PM
Jun-01-22 06:00AM
May-03-22 06:00AM
11:20AM Loading…
Mar-30-22 11:20AM
Feb-11-22 04:30PM
Jan-28-22 09:38AM
Jan-20-22 04:40PM
Jan-05-22 04:55PM
Nov-15-21 08:00AM
Nov-09-21 07:00AM
Oct-15-21 07:44AM
Sep-30-21 12:50PM
Sep-29-21 03:37AM
Sep-28-21 02:37PM
Aug-20-21 12:19PM
Aug-19-21 01:19PM
Aug-16-21 04:15PM
Jul-15-21 03:51PM
Jul-14-21 07:56PM
Mar-31-21 04:10PM
Mar-11-21 09:00PM
Mar-09-21 08:15PM
Mar-04-21 05:03PM
Feb-19-21 05:07PM
Feb-16-21 05:30PM
Feb-15-21 03:45PM
Feb-10-21 12:50PM
Feb-08-21 11:07AM
Feb-02-21 08:00AM
Feb-01-21 03:47PM
Jan-28-21 04:30PM
Jan-27-21 02:30PM
Jan-18-21 06:00PM
Jan-14-21 11:45AM
Jan-11-21 05:30PM
Dec-24-20 04:07PM
Dec-23-20 12:40AM
Dec-19-20 11:35PM
Dec-17-20 06:17PM
Dec-16-20 04:47PM
Dec-12-20 08:08PM
Dec-11-20 10:37AM
Dec-10-20 04:10PM
Dec-09-20 11:30PM
Dec-08-20 03:47PM
Dec-07-20 08:13PM
Dec-05-20 09:20PM
Dec-02-20 02:15PM
Dec-01-20 01:15PM
Nov-30-20 09:00PM
Nov-29-20 07:45AM
Nov-27-20 10:17AM
Nov-26-20 01:00PM
Nov-25-20 11:20PM
Nov-24-20 08:47PM
Sonoma Pharmaceuticals, Inc. engages in the development and production of hypochlorous acid (HOCl) products for wound care, animal health care, eye care, nasal care, oral care and dermatological conditions. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Boulder, CO.